Company Profile
Akebia Therapeutics Stock Price, News & Analysis
- Ticker:
- AKBA
- Exchange:
- NASDAQ
- Sector:
- Biotechnology
- Location:
- Headquartered in the United States and listed on NASDAQ, Akebia Therapeutics is followed within the biopharmaceutical universe for its exposure to pipeline and commercialization catalysts.
Stock performance
1.10 USD (+0.92%)
Close
Last updated: June 23, 2026 at 00:00
295.08M USD
Market cap
Why the stock is moving
AKBA is trading with a steady catalyst profile while investors wait for the next headline that changes the story.
Company overview
Business overview
Akebia Therapeutics is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
Geographic Base and Sector Classification
Headquartered in the United States and listed on NASDAQ, Akebia Therapeutics is followed within the biopharmaceutical universe for its exposure to pipeline and commercialization catalysts.
Business Model Characteristics
Akebia Therapeutics follows a pipeline-led model where clinical readouts, filing updates, and program expansion determine how the market underwrites the story.
Position Within the Biotechnology Landscape
Compared with more mature healthcare names, Akebia Therapeutics sits on the development side of the biotech landscape, where catalyst timing can reprice the stock quickly.
Future catalysts
Recent news
The five most recent feed items are shown below in reverse chronological order.
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of Akebia Therapeutics (AKBA)?
Akebia Therapeutics (AKBA) most recently closed at 1.10 USD, a +0.92% move versus the previous session.
What is the market cap of Akebia Therapeutics (AKBA)?
Akebia Therapeutics currently has a market capitalization of 295.08M USD on BioPharmSignal.
What does Akebia Therapeutics do?
Akebia Therapeutics is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
On which exchange is AKBA stock listed?
Akebia Therapeutics (AKBA) is associated with NASDAQ, Headquartered in the United States and listed on NASDAQ, Akebia Therapeutics is followed within the biopharmaceutical universe for its exposure to pipeline and commercialization catalysts., Biotechnology.
What is Akebia?
Akebia Therapeutics is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
Which conditions is Akebia Therapeutics targeting with Akebia?
Akebia Therapeutics is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
What is Therapeutics?
Akebia Therapeutics is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.